Healthcare provider profile · identity verified

Joey Brett, MD

Family Practice · VAN NUYS, CA · NPI 1831199017

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	870	292
Amlodipine Besylate	Amlodipine Besylate	387	127
Metformin Hcl	Metformin Hcl	387	133
Losartan Potassium	Losartan Potassium	337	113
Levothyroxine Sodium	Levothyroxine Sodium	290	94
Omeprazole	Omeprazole	256	103
Lisinopril	Lisinopril	248	84
Gabapentin	Gabapentin	228	81
Tamsulosin Hcl	Tamsulosin Hcl	191	65
Alendronate Sodium	Alendronate Sodium	171	56
Trazodone Hcl	Trazodone Hcl	171	61
Metoprolol Succinate	Metoprolol Succinate	156	54
Simvastatin	Simvastatin	148	46
Albuterol Sulfate Hfa	Albuterol Sulfate	146	49
Benazepril Hcl	Benazepril Hcl	143	50
Metoprolol Tartrate	Metoprolol Tartrate	134	40
Fluticasone Propionate	Fluticasone Propionate	133	56
Pantoprazole Sodium	Pantoprazole Sodium	128	54
Rosuvastatin Calcium	Rosuvastatin Calcium	102	36
Valsartan	Valsartan	95	33
Furosemide	Furosemide	94	32
Hydrochlorothiazide	Hydrochlorothiazide	94	37
Januvia	Sitagliptin Phosphate	93	30
Carvedilol	Carvedilol	92	29
Fenofibrate	Fenofibrate	84	27
Glipizide Er	Glipizide	82	27
Glipizide	Glipizide	81	25
Montelukast Sodium	Montelukast Sodium	73	24
Donepezil Hcl	Donepezil Hcl	72	23
Famotidine	Famotidine	72	27
Pravastatin Sodium	Pravastatin Sodium	71	26
Olmesartan Medoxomil	Olmesartan Medoxomil	67	22
Diclofenac Sodium	Diclofenac Sodium	65	37
Ibuprofen	Ibuprofen	65	28
Alprazolam	Alprazolam	64	19
Finasteride	Finasteride	64	26
Escitalopram Oxalate	Escitalopram Oxalate	61	18
Atenolol	Atenolol	60	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	18
Clonazepam	Clonazepam	54	19
Farxiga	Dapagliflozin Propanediol	52	14
Pioglitazone Hcl	Pioglitazone Hcl	51	14
Eliquis	Apixaban	50	22
Clopidogrel	Clopidogrel Bisulfate	49	19
Hydralazine Hcl	Hydralazine Hcl	49	18
Sertraline Hcl	Sertraline Hcl	47	17
Meloxicam	Meloxicam	46	22
Jardiance	Empagliflozin	45	15
Nifedipine Er	Nifedipine	42	15
Chlorthalidone	Chlorthalidone	41	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	41	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	39	12
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Valacyclovir	Valacyclovir Hcl	37	18
Zolpidem Tartrate	Zolpidem Tartrate	37	15
Allopurinol	Allopurinol	35	11
Naproxen	Naproxen	34	21
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Meclizine Hcl	Meclizine Hcl	32	18
Ozempic	Semaglutide	32	suppressed
Tramadol Hcl	Tramadol Hcl	31	17
Propranolol Hcl	Propranolol Hcl	30	suppressed
Azithromycin	Azithromycin	29	27
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	22
Glimepiride	Glimepiride	25	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	24	suppressed
Acarbose	Acarbose	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Baclofen	Baclofen	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	19	suppressed
Felodipine Er	Felodipine	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Azelastine Hcl	Azelastine Hcl	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Dutasteride	Dutasteride	15	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	14
Warfarin Sodium	Warfarin Sodium	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	13	suppressed
Invokana	Canagliflozin	13	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	11	suppressed
Nystatin	Nystatin	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error